199 related articles for article (PubMed ID: 17549347)
21. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
22. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
23. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.
Liston P; Fong WG; Kelly NL; Toji S; Miyazaki T; Conte D; Tamai K; Craig CG; McBurney MW; Korneluk RG
Nat Cell Biol; 2001 Feb; 3(2):128-33. PubMed ID: 11175744
[TBL] [Abstract][Full Text] [Related]
24. Low expression of XIAP-associated factor 1 in human colorectal cancers.
Ma TL; Ni PH; Zhong J; Tan JH; Qiao MM; Jiang SH
Chin J Dig Dis; 2005; 6(1):10-4. PubMed ID: 15667552
[TBL] [Abstract][Full Text] [Related]
25. [Expression and subcellular localization of XIAP and XAF1 in human normal oral keratinocytes and Tca8113 cells].
Gao WX; Wang X; Wei XF; Chen YX; Zhang J; Zhu LK
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):682-3. PubMed ID: 17331366
[TBL] [Abstract][Full Text] [Related]
26. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
27. [Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].
Sun B; Wang B; Zhao X
Zhonghua Gan Zang Bing Za Zhi; 2000 Feb; 8(1):37-9. PubMed ID: 10712784
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
30. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
31. Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule.
Kikkawa Y; Sudo R; Kon J; Mizuguchi T; Nomizu M; Hirata K; Mitaka T
Exp Cell Res; 2008 Aug; 314(14):2579-90. PubMed ID: 18635166
[TBL] [Abstract][Full Text] [Related]
32. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.
Matsumoto E; Nakatsukasa H; Nouso K; Kobayashi Y; Nakamura S; Suzuki M; Takuma Y; Tanaka H; Fujikawa T; Shiratori Y
Liver Int; 2004 Aug; 24(4):379-83. PubMed ID: 15287862
[TBL] [Abstract][Full Text] [Related]
33. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
[TBL] [Abstract][Full Text] [Related]
36. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
37. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
Peng SH; Yang JF; Xie PP; Deng H; Li H; Feng DY
Ai Zheng; 2005 Jun; 24(6):695-8. PubMed ID: 15946481
[TBL] [Abstract][Full Text] [Related]
38. Induction and redistribution of XAF1, a new antagonist of XIAP in the rat brain after transient focal ischemia.
Siegelin M; Touzani O; Toutain J; Liston P; Rami A
Neurobiol Dis; 2005 Nov; 20(2):509-18. PubMed ID: 15905097
[TBL] [Abstract][Full Text] [Related]
39. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
